Active Not Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03475212

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES)

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (ACES) PBMTC SUP1701

Sponsor: Pediatric Transplantation & Cellular Therapy Consortium

Conditions Adenovirus Infection Cytomegalovirus Infections EBV Infection

Interventions Virus Specific T-cell (VST) infusion

Updated 20 times since 2018 Last updated: May 6, 2025 Started: Jun 20, 2018 Primary completion: Jun 30, 2025 Completion: Jun 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Adenovirus Infection and Cytomegalovirus Infections and is currently ongoing. Pediatric Transplantation & Cellular Therapy Consortium leads this study, which shows 20 recorded versions since 2018 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

20 versions recorded

Sep 2025 — Present [monthly]

Active Not Recruiting PHASE1/PHASE2
Jun 2025 — Sep 2025 [monthly]

Active Not Recruiting PHASE1/PHASE2
Sep 2024 — Jun 2025 [monthly]

Active Not Recruiting PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2024 — Jul 2024 [monthly]

Active Not Recruiting PHASE1_PHASE2

▶ Show 15 earlier versions

Dec 2023 — Jan 2024 [monthly]

Active Not Recruiting PHASE1_PHASE2
May 2023 — Dec 2023 [monthly]

Active Not Recruiting PHASE1_PHASE2
Apr 2022 — May 2023 [monthly]

Active Not Recruiting PHASE1_PHASE2
Feb 2021 — Apr 2022 [monthly]

Active Not Recruiting PHASE1_PHASE2

Status: Recruiting → Active Not Recruiting
Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE1_PHASE2
Aug 2020 — Jan 2021 [monthly]

Recruiting PHASE1_PHASE2
Apr 2020 — Aug 2020 [monthly]

Recruiting PHASE1_PHASE2

Status: Active Not Recruiting → Recruiting
Feb 2020 — Apr 2020 [monthly]

Active Not Recruiting PHASE1_PHASE2
Dec 2019 — Feb 2020 [monthly]

Active Not Recruiting PHASE1_PHASE2

Status: Recruiting → Active Not Recruiting
Jun 2019 — Dec 2019 [monthly]

Recruiting PHASE1_PHASE2
May 2019 — Jun 2019 [monthly]

Recruiting PHASE1_PHASE2
Nov 2018 — May 2019 [monthly]

Recruiting PHASE1_PHASE2
Aug 2018 — Nov 2018 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Aug 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Apr 2018 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pediatric Transplantation & Cellular Therapy Consortium

Data source: Pediatric Transplantation & Cellular Therapy Consortium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Atlanta, United States , Aurora, United States , Boston, United States , Buffalo, United States , Charleston, United States , Chicago, United States , Dallas, United States , Duarte, United States , Durham, United States and 17 more locations